4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-030482
SVP, Head of Finance & Admin. sold 88,924 shares at an average $26.19 ($2,329,007)
- SVP, Head of Finance & Admin. acquired 86,252 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Scalzo Richard William SVP, Head of Finance & Admin. | 2024-03-08 | Option exercise 10b5-1 | +68,919 | $5.54 | $381,811 | 190,874 | D |
| Scalzo Richard William SVP, Head of Finance & Admin. | 2024-03-08 | Option exercise 10b5-1 | +17,333 | $5.54 | $96,025 | 208,207 | D |
| Scalzo Richard William SVP, Head of Finance & Admin. | 2024-03-08 | Sale 10b5-1 | −30,755 | $25.31 | $778,409 | 177,452 | D |
| Scalzo Richard William SVP, Head of Finance & Admin. | 2024-03-08 | Sale 10b5-1 | −55,208 | $26.72 | $1,475,158 | 122,244 | D |
| Scalzo Richard William SVP, Head of Finance & Admin. | 2024-03-08 | Sale 10b5-1 | −289 | $27.33 | $7,898 | 121,955 | D |
| Scalzo Richard William SVP, Head of Finance & Admin. | 2024-03-11 | Sale 10b5-1 | −1,082 | $25.70 | $27,807 | 120,873 | D |
| Scalzo Richard William SVP, Head of Finance & Admin. | 2024-03-11 | Sale 10b5-1 | −1,590 | $24.99 | $39,734 | 119,283 | D |
| Derivatives | |||||||
| Scalzo Richard William SVP, Head of Finance & Admin. | 2024-03-08 | Option exercise · Stock option (right to buy) 10b5-1 | −68,919 | 9,855 | D | ||
| Scalzo Richard William SVP, Head of Finance & Admin. | 2024-03-08 | Option exercise · Stock option (right to buy) 10b5-1 | −17,333 | 0 | D | ||
| Open-market sales · 88,924 sh · avg $26.19 · $2,329,007 | |||||||
Loading xslF345X05/ownership.xml…